J
Jørgen Viby-Mogensen
Researcher at Copenhagen University Hospital
Publications - 87
Citations - 5817
Jørgen Viby-Mogensen is an academic researcher from Copenhagen University Hospital. The author has contributed to research in topics: Cholinesterase & Neuromuscular transmission. The author has an hindex of 36, co-authored 87 publications receiving 5589 citations. Previous affiliations of Jørgen Viby-Mogensen include University of Copenhagen & Queen's University Belfast.
Papers
More filters
Journal ArticleDOI
Residual neuromuscular block is a risk factor for postoperative pulmonary complications: A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium
H. Berg,Jørgen Viby-Mogensen,J. Roed,C. R. Mortensen,J. Engbæk,L. T. Skovgaard,J. J. Krintel +6 more
TL;DR: The aim of this study was to compare the incidence of POPC following the use of pancuronium, atracurium, and vecuronium and to examine the effect of residual neuromuscular block on the incidence.
Journal ArticleDOI
Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision.
Thomas Fuchs-Buder,C. Claudius,Lene Theil Skovgaard,L. I. Eriksson,Rajinder K. Mirakhur,Jørgen Viby-Mogensen +5 more
TL;DR: The set of guidelines for good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents, which was developed following an international consensus conference in Copenhagen, has been revised and updated.
Journal ArticleDOI
Good Clinical Research Practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents
Jørgen Viby-Mogensen,J. Engbæk,L. I. Eriksson,L. Gramstad,Erik W. Jensen,F. S. Jensen,Z. J. Koscielniak-Nielsen,Lene Theil Skovgaard,Doris Østergaard +8 more
TL;DR: The guidelines are intended to be a help for people working in this research field, and it is hoped that the guidelines will assist researchers, editors, and drug companies to enhance the quality of their pharmacodynamic studies of neuromuscular blocking agents.
Journal ArticleDOI
Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study.
Iben Foss Sorgenfrei,Kathrine Norrild,Per Bo Larsen,Jakob Stensballe,Doris Østergaard,Martine E. Prins,Jørgen Viby-Mogensen +6 more
TL;DR: At doses of 2.0mg/kg or greater, sugammadex safely reversed 0.6 mg/kg rocuronium–induced neuromuscular block in a dose-dependent manner and was safe and well tolerated.
Journal ArticleDOI
Tactile and visual evaluation of the response to train-of-four nerve stimulation.
Jørgen Viby-Mogensen,Niels Henrik Jensen,J. Engbæk,H. Ørding,Lene Theil Skovgaard,Bent Chraemmer-Jørgensen +5 more
TL;DR: L'evaluation manuelle de la reponse a la stimulation nerveuse «train de quatre» permet l'ajustement des posologies individuelles pour les curarisants au cours de l'anesthesie pour eviter un surdosage and assurer la reversibilite.